Skip to content

Clinical trials

Terminated Phase 1/2 trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Status: Terminated Country / region: Hong Kong Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20093
20121
20192
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Alentis Therapeutics AG1
Cullinan Therapeutics Inc.1
GlaxoSmithKline1
New Beta Innovation Limited1
Omega Therapeutics1
Pfizer1
Proacta, Incorporated1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular2
Hepatitis B, Chronic2
Squamous Cell Carcinoma of Head and Neck2
Bronchiolitis Obliterans Syndrome1
Chronic Limb-Threatening Ischemia1
Epstein-Barr Virus Infections1
Head and Neck Neoplasms1
Hepatitis B1
Hereditary Sensory and Autonomic Neuropathies1
Liver Neoplasms1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.